Clinical PK Study Analysis
Pharsight scientists use the latest versions of Phoenix WinNonlin, Phoenix NLME, WinNonlin AutoPilot and Pharsight Knowledgebase Server (PKS) to ensure that your analyses are carried out to the highest professional standards, in minimum time, at competitive rates.
Phase I Studies (healthy subjects in general)
- Maximum tolerated dose (MTD) Studies
- Single Ascending Dose (SAD) studies
- Multiple Ascending Dose (MAD) studies
- Bioequivalence/bioavailability
- Food effect studies
- Drug-drug interaction studies
- Studies in special populations (e.g., renally and hepatically impaired)
- QT prolongation studies
Phase II Studies in patients for dosing requirements (Phase IIa) and efficacy
(Phase IIb)
- Designs and workplans are specific to your drug indication
Pharsight methods are simple, efficient, and robust. You receive the highest quality analysis, leading to protocols optimized for:
- Number of samples -- a key cost driver
- Sampling schedule -- to improve your picture of PK
- Dose
- Populations